There is broad recognition of the need to promote diversity and inclusion in clinical trials, with the goal of improving ...

The headline result from the MATINEE trial of IL-5 inhibitor Nucala (mepolizumab) in adults with COPD was a statistically ...

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), ...

AstraZeneca has confirmed that some of its current and former employees have been taken into custody in China as part of an ...

The agreement ties in with Lilly's strategy of making genetic medicines targeting DNA and RNA a key pillar of its R&D, ...

The CEO's departure comes after Lykos co-founder and longtime psychedelic medicines advocate Rick Doblin stood down from the ...

Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies ...

J&J has taken all its talc-based products off the market as of 2023 and is now using cornstarch instead. In its ...

Now, in a stunning reversal, Advanz has won a reprieve after the General Court of the European Union ordered a suspension of ...

The company recently claimed FDA approval for the first description DTx for major depressive disorder (MDD) – ...

The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance ...

Pay a tax of up to 1,900% (not 95%) on the total sales revenue of the medicine selected for price setting. News coverage ...